AstraZeneca SWOT Analysis, Competitors & USP

AstraZeneca

Parent Company

AstraZeneca Biopharmaceuticals

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Health connects us all

USP

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

AstraZeneca STP

Segment

Cardiovascular, neuroscience, gastrointestinal, oncology, infection & respiratory diseases

Target Group

Healthcare professionals, doctors, hospitals offering treatments for above mentioned diseases

Positioning

They are responsible for development of prescription medicines for six important areas of healthcare such as cancer, infection.

AstraZeneca SWOT Analysis

Strengths

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of AstraZeneca :

1. Rapid decision making & streamlined due diligence processing

2. Good commercial and R&D presence in emerging markets

3. Active in over 100 countries employing over 60,000 people

4. High investment in R&D with 11,000+ dedicated R&D team

5. Ten products with global sales above 1 billion dollar
6. Product portfolio includes cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation medicines

Weakness

1. It was affected by drug shortage crisis as in case of Cefotan

2. Product discontinuation affects the performance

3. Legal proceedings related to patents and pricing issues affect image

Opportunities

1. It can leverage its strong presence in emerging markets

2. Increasing importance of biosimiler market

3. Increasing global ageing population

Threats

1. Seroquel  their blockbuster drug is facing threat of copycat generic drugs

2. Stringent drug development guidelines
3. Competition coming up with effective drugs

AstraZeneca Competition

Competitors

Below are the 4 main AstraZeneca competitors :

1. Amgen
2. Genentech

3. Teva Pharmaceuticals

4. GlaxoSmithKline